| Discipline name | D-Index | World Ranking | Current World Ranking | National Ranking | Current National Ranking | Publications | Citations |
|---|---|---|---|---|---|---|---|
| Molecular Biology | 50 | 2555 | 2307 | 5 | 5 | 237 | 10465 |
The chart shows the history of publications by Jan Trka between 1995 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Jan Trka published across 31 years, from 1995 to 2025, averaging 12.1 papers a year. Output peaked at 49 publications in 2024. 56 of the 374 publications appeared in the last two years.
374 publications in total across all disciplines
| Year | Publications |
|---|---|
| 1995 | 1 |
| 1996 | 0 |
| 1997 | 0 |
| 1998 | 3 |
| 1999 | 5 |
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 7 |
| 2003 | 7 |
| 2004 | 9 |
| 2005 | 12 |
| 2006 | 12 |
| 2007 | 11 |
| 2008 | 19 |
| 2009 | 16 |
| 2010 | 17 |
| 2011 | 14 |
| 2012 | 13 |
| 2013 | 12 |
| 2014 | 24 |
| 2015 | 14 |
| 2016 | 17 |
| 2017 | 13 |
| 2018 | 17 |
| 2019 | 16 |
| 2020 | 9 |
| 2021 | 8 |
| 2022 | 13 |
| 2023 | 25 |
| 2024 | 49 |
| 2025 | 7 |
| Total | 374 |
The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Jan Trka sits on this spectrum.
This scientist: 237 publications — 69th percentile
69% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 564 publications or more.
| Publications | Scientists | This scientist |
|---|---|---|
| 47–56 | 7 | |
| 57–66 | 17 | |
| 67–76 | 65 | |
| 77–86 | 90 | |
| 87–96 | 125 | |
| 97–106 | 131 | |
| 107–116 | 162 | |
| 117–126 | 177 | |
| 127–136 | 158 | |
| 137–146 | 158 | |
| 147–156 | 146 | |
| 157–166 | 159 | |
| 167–176 | 131 | |
| 177–186 | 110 | |
| 187–196 | 112 | |
| 197–206 | 100 | |
| 207–216 | 89 | |
| 217–226 | 98 | |
| 227–236 | 74 | |
| 237–246 | 72 | 237 |
| 247–256 | 63 | |
| 257–266 | 53 | |
| 267–276 | 54 | |
| 277–286 | 49 | |
| 287–296 | 52 | |
| 297–306 | 43 | |
| 307–316 | 46 | |
| 317–326 | 41 | |
| 327–336 | 42 | |
| 337–346 | 31 | |
| 347–356 | 28 | |
| 357–366 | 29 | |
| 367–376 | 26 | |
| 377–386 | 24 | |
| 387–396 | 24 | |
| 397–406 | 14 | |
| 407–416 | 13 | |
| 417–426 | 20 | |
| 427–436 | 12 | |
| 437–446 | 20 | |
| 447–456 | 11 | |
| 457–466 | 10 | |
| 467–476 | 14 | |
| 477–486 | 14 | |
| 487–496 | 10 | |
| 497–506 | 13 | |
| 507–516 | 13 | |
| 517–526 | 2 | |
| 527–536 | 4 | |
| 537–546 | 6 | |
| 547–556 | 8 | |
| 557–563 | 6 | |
| 564+ | 100 |
The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Jan Trka sits on this spectrum.
This scientist: 50 D-Index — 18th percentile
18% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 145 D-Index or more.
| D-Index | Scientists | This scientist |
|---|---|---|
| 40–41 | 36 | |
| 42–43 | 101 | |
| 44–45 | 115 | |
| 46–47 | 121 | |
| 48–49 | 118 | |
| 50–51 | 130 | 50 |
| 52–53 | 106 | |
| 54–55 | 116 | |
| 56–57 | 113 | |
| 58–59 | 129 | |
| 60–61 | 120 | |
| 62–63 | 105 | |
| 64–65 | 131 | |
| 66–67 | 95 | |
| 68–69 | 97 | |
| 70–71 | 106 | |
| 72–73 | 83 | |
| 74–75 | 89 | |
| 76–77 | 77 | |
| 78–79 | 70 | |
| 80–81 | 73 | |
| 82–83 | 60 | |
| 84–85 | 48 | |
| 86–87 | 45 | |
| 88–89 | 50 | |
| 90–91 | 31 | |
| 92–93 | 51 | |
| 94–95 | 43 | |
| 96–97 | 38 | |
| 98–99 | 39 | |
| 100–101 | 41 | |
| 102–103 | 29 | |
| 104–105 | 33 | |
| 106–107 | 35 | |
| 108–109 | 20 | |
| 110–111 | 38 | |
| 112–113 | 19 | |
| 114–115 | 28 | |
| 116–117 | 13 | |
| 118–119 | 23 | |
| 120–121 | 16 | |
| 122–123 | 15 | |
| 124–125 | 11 | |
| 126–127 | 21 | |
| 128–129 | 7 | |
| 130–131 | 13 | |
| 132–133 | 14 | |
| 134–135 | 17 | |
| 136–137 | 9 | |
| 138–139 | 8 | |
| 140–141 | 16 | |
| 142–143 | 7 | |
| 144 | 7 | |
| 145+ | 100 |
Jan Trka is affiliated with Charles University in the Czech Republic and has a research focus spanning Medicine, Biochemistry, Genetics, and Molecular Biology. Their work covers several subfields including Public Health, Environmental and Occupational Health, Hematology, Molecular Biology, Genetics, and Pediatrics, Perinatology and Child Health.
Their research topics primarily emphasize Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, and Chronic Myeloid Leukemia Treatments. Other significant areas include Childhood Cancer Survivors' Quality of Life, Chronic Lymphocytic Leukemia Research, Cancer Genomics and Diagnostics, and Lymphoma Diagnosis and Treatment.
Frequent coauthors collaborating with Jan Trka include Markéta Žaliová, Jan Starý, Jan Zuna, Eva Froňková, and Lucie Šrámková. Their publications have appeared predominantly in the journals Blood, Leukemia, HemaSphere, Haematologica, and Blood Advances.
Notable recent papers authored or coauthored by Jan Trka highlight various aspects of leukemia research:
V H J van der Velden;G Cazzaniga;A Schrauder;J Hancock
C Meyer;T Burmeister;D Gröger;G Tsaur
C. Meyer;J. Hofmann;T. Burmeister;D. Gröger
C. Meyer;E. Kowarz;J. Hofmann;A. Renneville
Dani Bercovich;Ithamar Ganmore;Linda M. Scott;Gilad Wainreb
Jan Stary;Martin Zimmermann;Myriam Campbell;Luis Castillo
Prisca Theunissen;Ester Mejstrikova;Lukasz Sedek;Alita J. van der Sluijs-Gelling
Iris H.I.M. Hollink;Marry M. van den Heuvel-Eibrink;Susan T.C.J.M. Arentsen-Peters;Marta Pratcorona
Liat Rainis;Dan Bercovich;Sabine Strehl;Andrea Teigler-Schlegel
C. Meyer;B. Schneider;S. Jakob;S. Strehl
Monika Brüggemann;Michaela Kotrová;Henrik Knecht;Jack Bartram
J D E de Rooij;I H I M Hollink;S T C J M Arentsen-Peters;J F van Galen
Arian van der Veer;Marketa Zaliova;Marketa Zaliova;Federica Mottadelli;Paola De Lorenzo
Iris H. I. M. Hollink;Marry M. van den Heuvel-Eibrink;Martin Zimmermann;Brian V. Balgobind
Anindita Basak;Miroslava Hancarova;Jacob C. Ulirsch;Tugce B. Balci
J Trka;M Kalinová;O Hrusák;J Zuna
Lucie Sramkova;Katerina Muzikova;Eva Fronkova;Ondrej Krejci
Brian V. Balgobind;Marry M. Van den Heuvel-Eibrink;Renee X. De Menezes;Dirk Reinhardt
E Ellinghaus;M Stanulla;G Richter;D Ellinghaus
Nir Gefen;Vera Binder;Vera Binder;Marketa Zaliova;Yvonne Linka
If you think any of the details on this page are incorrect, let us know.
Pursuing a degree in Molecular Biology can open the door to many interdisciplinary career paths, especially when paired with online learning options. Students from non-traditional backgrounds are increasingly choosing programs that help them bridge the gap into healthcare and life sciences roles.
For example, if you have a background in communication sciences but are interested in moving toward clinical practice, speech pathology bridge programs online are a popular and flexible way to qualify for licensure. Similarly, individuals without a nursing degree can take advantage of accelerated nursing programs for non nurses online, allowing a faster track into the nursing profession.
Advanced practice roles are also accessible online. Many aspiring professionals want to know how long does it take to be a nurse practitioner, as these programs offer a combination of convenience and career advancement. For those considering specialized fields, understanding the earning potential—such as the dnp pmhnp salary—can further guide your education and career planning.
Shenzhen Institutes of Advanced Technology
University of California, San Diego
IMT Institute for Advanced Studies Lucca
Pennsylvania State University
University of Oxford
University of Nevada, Las Vegas
University of Illinois at Chicago
Roma Tre University
National Institutes of Health
Kyoto University
Roswell Park Cancer Institute
University of South Australia
University of Huelva
Nanjing University of Science and Technology
University of Essex
Stanford University
